Join Growin Stock Community!

安基生技7754.TW Overview

TW StockBiotech. & Medical
(No presentation for 7754)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

安基生技（7754）Overall Performance

安基生技（7754）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

安基生技（7754） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

安基生技（7754）Key Information

安基生技（7754）Profile

AnnJi Pharmaceutical Co., Ltd. develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders. It develops therapeutics, such as AJ201 for the treatment of spinal and bulbar muscular atrophy, a neurodegenerative disease; AJ202 for androgenetic alopecia; AJ302, a histone deacetylase 6 inhibitor for the prevention and treatment of chemotherapy-induced peripheral neuropathy; and AJ303, an anti-fibrotic and anti-inflammatory compound for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. AnnJi Pharmaceutical Co., Ltd. was founded in 2014 and is based in Taipei, Taiwan.

安基生技（7754）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

No related data records

default symbol

7754

安基生技

59.00D

-1.19%

(-0.01)

  • When is 7754's latest earnings report released?

    The most recent financial report for 安基生技 (7754) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 7754's short-term business performance and financial health. For the latest updates on 7754's earnings releases, visit this page regularly.

  • How much cash does 7754 have?

    At the end of the period, 安基生技 (7754) held Total Cash and Cash Equivalents of 427.55M, accounting for 0.55 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 7754 go with three margins increasing?

    In the latest report, 安基生技 (7754) did not achieve the “three margins increasing” benchmark, with a gross margin of 13.75%%, operating margin of -2,493.68%%, and net margin of -2,231.85%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 7754's profit trajectory and future growth potential.